Training activity information
Details
Analyse the appropriate genetic tests for pharmacogenetic testing in oncology patients, to include:
- DPYD
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
Considerations are suggestions about what may be useful for the trainee to think about while undertaking a training activity. They should not be considered as a mandatory checklist. Trainees should not be expected to demonstrate or provide evidence for each of the considerations listed.
- Principles of the assays
- Disease mechanism
- Best practice guidance
- Local and national guidance
- Incidental findings
- Quality control, including IQC, and EQA
- Nomenclature
- Sensitivity and limitations
- Local SOPs
- Health and safety
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 6 |
Outcome
Analyse, interpret and report pharmacogenetic testing in oncology patients. |